GeoVax Historical Cash Flow
| GOVXW Stock | USD 0.12 0.01 9.09% |
Analysis of GeoVax Labs cash flow over time is an excellent tool to project GeoVax Labs future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Other Cashflows From Financing Activities of 4.3 M or Depreciation of 70.5 K as it is a great indicator of GeoVax Labs ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining GeoVax Labs latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether GeoVax Labs is a good buy for the upcoming year.
GeoVax |
About GeoVax Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in GeoVax balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which GeoVax's non-liquid assets can be easily converted into cash.
GeoVax Labs Cash Flow Chart
Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Total Cashflows From Investing Activities
The net amount of cash used in or generated from a company's investment activities, such as purchasing or selling assets, during a reporting period.Most accounts from GeoVax Labs' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into GeoVax Labs current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GeoVax Labs. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. For more information on how to buy GeoVax Stock please use our How to Invest in GeoVax Labs guide.At this time, GeoVax Labs' Sale Purchase Of Stock is fairly stable compared to the past year. Begin Period Cash Flow is likely to climb to about 29 M in 2024, despite the fact that Change In Cash is likely to grow to (20.1 M).
GeoVax Labs cash flow statement Correlations
Click cells to compare fundamentals
GeoVax Labs Account Relationship Matchups
High Positive Relationship
High Negative Relationship
GeoVax Labs cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Sale Purchase Of Stock | 1.6M | 1.2M | 1.4M | 11.5M | (1K) | 0.0 | |
| Change In Cash | 23.6K | 9.6M | 1.5M | 16.2M | (21.2M) | (20.1M) | |
| Free Cash Flow | (1.4M) | (2.9M) | (11.2M) | (19.2M) | (25.2M) | (24.0M) | |
| Change In Working Capital | 636.3K | (806.0) | 6.9M | (6.0M) | (356.0K) | (338.2K) | |
| Begin Period Cash Flow | 259.7K | 283.3K | 9.9M | 11.4M | 27.6M | 29.0M | |
| Other Cashflows From Financing Activities | 1.4M | 11.8M | 3.4M | 7.6M | 4.1M | 4.3M | |
| Depreciation | 8.4K | 19.7K | 38.5K | 56.3K | 74.2K | 70.5K | |
| Other Non Cash Items | (348.3K) | 124.2K | 37.8K | 3.7M | (1.2T) | (1.2T) | |
| Capital Expenditures | 7.6K | 156.8K | 47.7K | 134.3K | 48.9K | 46.5K | |
| Total Cash From Operating Activities | (1.4M) | (2.8M) | (11.2M) | (19.0M) | (25.2M) | (23.9M) | |
| Net Income | (2.4M) | (3.0M) | (18.6M) | (14.0M) | (26.0M) | (24.7M) | |
| Total Cash From Financing Activities | 1.4M | 12.5M | 12.8M | 35.4M | 4.1M | 5.1M | |
| End Period Cash Flow | 283.3K | 9.9M | 11.4M | 27.6M | 6.5M | 3.3M | |
| Stock Based Compensation | 327.5K | 64.5K | 370.0K | 902.1K | 1.1M | 1.1M | |
| Change To Account Receivables | 53.2K | (114.1K) | 133.7K | 49.0K | 56.4K | 59.2K | |
| Investments | (7.6K) | (156.8K) | (47.7K) | (134.3K) | (48.9K) | (51.4K) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for GeoVax Stock Analysis
When running GeoVax Labs' price analysis, check to measure GeoVax Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeoVax Labs is operating at the current time. Most of GeoVax Labs' value examination focuses on studying past and present price action to predict the probability of GeoVax Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeoVax Labs' price. Additionally, you may evaluate how the addition of GeoVax Labs to your portfolios can decrease your overall portfolio volatility.